Andrew P Landstrom1, Andrew L Dailey-Schwartz2, Jill A Rosenfeld2, Yaping Yang2, Margaret J McLean2, Christina Y Miyake2, Santiago O Valdes2, Yuxin Fan2, Hugh D Allen2, Daniel J Penny2, Jeffrey J Kim1. 1. From the Department of Pediatrics, Section of Pediatric Cardiology (A.P.L., A.L.D.-S., C.Y.M., S.O.V., Y.F., H.D.A., D.J.P., J.J.K.) and Cardiovascular Research Institute (A.P.L., M.J.M.), Baylor College of Medicine, Houston, TX; and Baylor Miraca Genetics Laboratories, Houston, TX (J.A.R., Y.Y.). landstro@bcm.edu jjkim@texaschildrens.org. 2. From the Department of Pediatrics, Section of Pediatric Cardiology (A.P.L., A.L.D.-S., C.Y.M., S.O.V., Y.F., H.D.A., D.J.P., J.J.K.) and Cardiovascular Research Institute (A.P.L., M.J.M.), Baylor College of Medicine, Houston, TX; and Baylor Miraca Genetics Laboratories, Houston, TX (J.A.R., Y.Y.).
Abstract
BACKGROUND: The rapid expansion of genetic testing has led to increased utilization of clinical whole-exome sequencing (WES). Clinicians and genetic researchers are being faced with assessing risk of disease vulnerability from incidentally identified genetic variants which is typified by variants found in genes associated with sudden death-predisposing catecholaminergic polymorphic ventricular tachycardia (CPVT). We sought to determine whether incidentally identified variants in genes associated with CPVT from WES clinical testing represent disease-associated biomarkers. METHODS AND RESULTS: CPVT-associated genes RYR2 and CASQ2 variants were identified in one of the world's largest collections of clinical WES referral tests (N=6517, Baylor Miraca Genetics Laboratories) and compared with a control cohort of ostensibly healthy individuals (N=60 706) and a case cohort of CPVT cases (N=155). Within the WES cohort, the rate of rare variants in CPVT-associated genes was 8.8% compared with 6.0% among controls and 60.0% among cases. There was a predominance of variants of undetermined significance (97.7%). After protein topology mapping, WES variants colocalized more frequently to residues with variants found in controls compared with cases. Retrospective clinical evaluation of individuals referred to our institution with WES-positive variants demonstrated no evidence of clinical CPVT in individuals with a low pretest clinical suspicion for CPVT. CONCLUSIONS: The prevalence of incidentally identified CPVT-associated variants is ≈9% among WES tests. Variants of undetermined significances in CPVT-associated genes in WES genetic testing, in the absence of clinical suspicion for CPVT, are unlikely to represent markers of CPVT pathogenicity.
BACKGROUND: The rapid expansion of genetic testing has led to increased utilization of clinical whole-exome sequencing (WES). Clinicians and genetic researchers are being faced with assessing risk of disease vulnerability from incidentally identified genetic variants which is typified by variants found in genes associated with sudden death-predisposing catecholaminergic polymorphic ventricular tachycardia (CPVT). We sought to determine whether incidentally identified variants in genes associated with CPVT from WES clinical testing represent disease-associated biomarkers. METHODS AND RESULTS: CPVT-associated genes RYR2 and CASQ2 variants were identified in one of the world's largest collections of clinical WES referral tests (N=6517, Baylor Miraca Genetics Laboratories) and compared with a control cohort of ostensibly healthy individuals (N=60 706) and a case cohort of CPVT cases (N=155). Within the WES cohort, the rate of rare variants in CPVT-associated genes was 8.8% compared with 6.0% among controls and 60.0% among cases. There was a predominance of variants of undetermined significance (97.7%). After protein topology mapping, WES variants colocalized more frequently to residues with variants found in controls compared with cases. Retrospective clinical evaluation of individuals referred to our institution with WES-positive variants demonstrated no evidence of clinical CPVT in individuals with a low pretest clinical suspicion for CPVT. CONCLUSIONS: The prevalence of incidentally identified CPVT-associated variants is ≈9% among WES tests. Variants of undetermined significances in CPVT-associated genes in WES genetic testing, in the absence of clinical suspicion for CPVT, are unlikely to represent markers of CPVT pathogenicity.
Authors: Alex V Postma; Isabelle Denjoy; Theo M Hoorntje; Jean-Marc Lupoglazoff; Antoine Da Costa; Pascale Sebillon; Marcel M A M Mannens; Arthur A M Wilde; Pascale Guicheney Journal: Circ Res Date: 2002-10-18 Impact factor: 17.367
Authors: Yaping Yang; Donna M Muzny; Fan Xia; Zhiyv Niu; Richard Person; Yan Ding; Patricia Ward; Alicia Braxton; Min Wang; Christian Buhay; Narayanan Veeraraghavan; Alicia Hawes; Theodore Chiang; Magalie Leduc; Joke Beuten; Jing Zhang; Weimin He; Jennifer Scull; Alecia Willis; Megan Landsverk; William J Craigen; Mir Reza Bekheirnia; Asbjorg Stray-Pedersen; Pengfei Liu; Shu Wen; Wendy Alcaraz; Hong Cui; Magdalena Walkiewicz; Jeffrey Reid; Matthew Bainbridge; Ankita Patel; Eric Boerwinkle; Arthur L Beaudet; James R Lupski; Sharon E Plon; Richard A Gibbs; Christine M Eng Journal: JAMA Date: 2014-11-12 Impact factor: 56.272
Authors: Stephan E Lehnart; Marco Mongillo; Andrew Bellinger; Nicolas Lindegger; Bi-Xing Chen; William Hsueh; Steven Reiken; Anetta Wronska; Liam J Drew; Chris W Ward; W J Lederer; Robert S Kass; Gregory Morley; Andrew R Marks Journal: J Clin Invest Date: 2008-06 Impact factor: 14.808
Authors: Jamie D Kapplinger; Andrew P Landstrom; J Martijn Bos; Benjamin A Salisbury; Thomas E Callis; Michael J Ackerman Journal: J Cardiovasc Transl Res Date: 2014-02-08 Impact factor: 4.132
Authors: Christina Y Miyake; Gregory Webster; Richard J Czosek; Michal J Kantoch; Anne M Dubin; Kishor Avasarala; Joseph Atallah Journal: Circ Arrhythm Electrophysiol Date: 2013-05-11
Authors: T Hubbard; D Andrews; M Caccamo; G Cameron; Y Chen; M Clamp; L Clarke; G Coates; T Cox; F Cunningham; V Curwen; T Cutts; T Down; R Durbin; X M Fernandez-Suarez; J Gilbert; M Hammond; J Herrero; H Hotz; K Howe; V Iyer; K Jekosch; A Kahari; A Kasprzyk; D Keefe; S Keenan; F Kokocinsci; D London; I Longden; G McVicker; C Melsopp; P Meidl; S Potter; G Proctor; M Rae; D Rios; M Schuster; S Searle; J Severin; G Slater; D Smedley; J Smith; W Spooner; A Stabenau; J Stalker; R Storey; S Trevanion; A Ureta-Vidal; J Vogel; S White; C Woodwark; E Birney Journal: Nucleic Acids Res Date: 2005-01-01 Impact factor: 16.971
Authors: Roddy Walsh; Kate L Thomson; James S Ware; Birgit H Funke; Jessica Woodley; Karen J McGuire; Francesco Mazzarotto; Edward Blair; Anneke Seller; Jenny C Taylor; Eric V Minikel; Daniel G MacArthur; Martin Farrall; Stuart A Cook; Hugh Watkins Journal: Genet Med Date: 2016-08-17 Impact factor: 8.822
Authors: Silvia G Priori; Carlo Napolitano; Mirella Memmi; Barbara Colombi; Fabrizio Drago; Maurizio Gasparini; Luciano DeSimone; Fernando Coltorti; Raffaella Bloise; Roberto Keegan; Fernando E S Cruz Filho; Gabriele Vignati; Abraham Benatar; Angelica DeLogu Journal: Circulation Date: 2002-07-02 Impact factor: 29.690
Authors: Hanna J Tadros; Chelsea S Life; Gustavo Garcia; Elisa Pirozzi; Edward G Jones; Susmita Datta; Michelle S Parvatiyar; P Bryant Chase; Hugh D Allen; Jeffrey J Kim; Jose R Pinto; Andrew P Landstrom Journal: J Mol Cell Cardiol Date: 2020-04-09 Impact factor: 5.000
Authors: Andrew P Landstrom; Ernesto Fernandez; Jill A Rosenfeld; Yaping Yang; Andrew L Dailey-Schwartz; Christina Y Miyake; Hugh D Allen; Daniel J Penny; Jeffrey J Kim Journal: Heart Rhythm Date: 2018-03-02 Impact factor: 6.343
Authors: Andrés R Pérez-Riera; Raimundo Barbosa-Barros; Marianne P C de Rezende Barbosa; Rodrigo Daminello-Raimundo; Augusto A de Lucca; Luiz C de Abreu Journal: Ann Noninvasive Electrocardiol Date: 2017-10-19 Impact factor: 1.468
Authors: Andrew L Dailey-Schwartz; Hanna J Tadros; Mahshid Sababi Azamian; Seema R Lalani; Shaine A Morris; Hugh D Allen; Jeffrey J Kim; Andrew P Landstrom Journal: J Pediatr Date: 2018-08-29 Impact factor: 4.406
Authors: Francisco J Alvarado; J Martijn Bos; Zhiguang Yuchi; Carmen R Valdivia; Jonathan J Hernández; Yan-Ting Zhao; Dawn S Henderlong; Yan Chen; Talia R Booher; Cherisse A Marcou; Filip Van Petegem; Michael J Ackerman; Héctor H Valdivia Journal: JCI Insight Date: 2019-03-05
Authors: Rachel L Draelos; Jordan E Ezekian; Farica Zhuang; Mary E Moya-Mendez; Zhushan Zhang; Michael B Rosamilia; Perathu K R Manivannan; Ricardo Henao; Andrew P Landstrom Journal: Circ Arrhythm Electrophysiol Date: 2022-03-31
Authors: Patrick S Connell; Amy M Berkman; BriAnna M Souder; Elisa J Pirozzi; Julia J Lovin; Jill A Rosenfeld; Pengfei Liu; Hari Tunuguntla; Hugh D Allen; Susan W Denfield; Jeffrey J Kim; Andrew P Landstrom Journal: Circ Genom Precis Med Date: 2020-11-23